Literature DB >> 3899106

Characterization of human interleukin 2 derived from Escherichia coli.

S M Liang, B Allet, K Rose, M Hirschi, C M Liang, D R Thatcher.   

Abstract

Interleukin 2 isolated from Escherichia coli cells expressing the human interleukin gene has been characterized. The observed properties of the protein have been compared with those properties which can be deduced from the DNA sequence alone and the published properties of natural human interleukin 2. The purified E. coli-derived interleukin 2 is a monomeric protein of Mr 15 000 with a sedimentation velocity of 1.86S. The amino acid composition of the protein and isoelectric point (7.7) are consistent with that part of the translated DNA sequence of the gene corresponding to the mature protein. A single disulphide bridge was identified between Cys-58 and Cys-105. C.d. suggested that interleukin 2 is predominantly alpha-helical in secondary structure. The E. coli-derived protein differed from natural interleukin 2 in the presence of N-terminal methionine and also in the absence of a carbohydrate moiety. Removal of the coding region for the first three amino acids of the natural interleukin 2 protein sequence (Ala-Pro-Thr) by site-specific mutagenesis resulted in a protein with N-terminal serine. The possibility that the specificity of the E. coli ribosomal methionine aminopeptidase may not recognize the sequence NH2-Met-Xaa-Pro is discussed (where Xaa is any amino acid residue).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899106      PMCID: PMC1145075          DOI: 10.1042/bj2290429

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The determination of sugar in blood and spinal fluid with anthrone reagent.

Authors:  J H ROE
Journal:  J Biol Chem       Date:  1955-01       Impact factor: 5.157

2.  Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.

Authors:  J R Ortaldo; A T Mason; J P Gerard; L E Henderson; W Farrar; R F Hopkins; R B Herberman; H Rabin
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

3.  Posttranslational modification of human T-cell growth factor.

Authors:  R J Robb; R M Kutny; M Panico; H Morris; W F DeGrado; V Chowdhry
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

Review 4.  Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor.

Authors:  R J Robb
Journal:  Immunobiology       Date:  1982-03       Impact factor: 3.144

5.  Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues.

Authors:  A Wang; S D Lu; D F Mark
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

6.  Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography.

Authors:  A Godard; J Naulet; M A Peyrat; H Vie; J F Moreau; J D Bignon; J P Soulillou
Journal:  J Immunol Methods       Date:  1984-05-25       Impact factor: 2.303

7.  Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.

Authors:  A S Stern; Y C Pan; D L Urdal; D Y Mochizuki; S DeChiara; R Blacher; J Wideman; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Purification of the T lymphocyte growth factor interleukin-2 from culture media of human peripheral blood leukocytes (buffy coats).

Authors:  E M Kniep; B Kniep; W Grote; H S Conradt; D A Monner; P F Mühlradt
Journal:  Eur J Biochem       Date:  1984-08-15

9.  Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells.

Authors:  S C Clark; S K Arya; F Wong-Staal; M Matsumoto-Kobayashi; R M Kay; R J Kaufman; E L Brown; C Shoemaker; T Copeland; S Oroszlan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  18 in total

1.  Enhancing the specificity of the enterokinase cleavage reaction to promote efficient cleavage of a fusion tag.

Authors:  S Hesam Shahravan; Xuanlu Qu; I-San Chan; Jumi A Shin
Journal:  Protein Expr Purif       Date:  2008-03-05       Impact factor: 1.650

2.  Regulation by glutathione of interleukin-4 activity on cytotoxic T cells.

Authors:  S M Liang; N Lee; D S Finbloom; C M Liang
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 4.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

5.  Preparation and characterization of bovine growth hormones produced in recombinant Escherichia coli.

Authors:  P T Wingfield; P Graber; G Buell; K Rose; M G Simona; B D Burleigh
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

6.  C-terminal peptide identification by fast atom bombardment mass spectrometry.

Authors:  K Rose; L A Savoy; M G Simona; R E Offord; P Wingfield
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

7.  Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.

Authors:  V Malkovska; J Murphy; L Hudson; D Bevan
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

8.  Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli.

Authors:  J L Schrimsher; K Rose; M G Simona; P Wingfield
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

9.  Purification and characterization of a high-molecular-weight form of recombinant human interleukin-2.

Authors:  Z Ahmad; D Ciolek; Y C Pan; H Michel; F R Khan
Journal:  J Protein Chem       Date:  1994-10

Review 10.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.